Niccolò Bitto/LinkedIn
Apr 10, 2026, 15:54
Niccolò Bitto: Answers to Some of the Most Frequently Asked Questions on Gene Therapy for Hemophilia
Niccolò Bitto, Internist at the Policlinic Hospital in Milan, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”An educational review that answers some of the most frequently asked questions on gene therapy for hemophilia, with a practical approach.
In particular, we shared our experience regarding hepatological management before and after this innovative therapy.
Thanks to Prof. Wolfgang Miesbach and Dr. Hoffmann”
Title: Overview of gene therapy for hemophilia: questions and answers to navigate the innovation
Authors: Pascal Hoffmann, Niccolò Bitto, Vincenzo La Mura, Wolfgang Miesbach
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 14, 2026, 16:50Peter Kouides: The Role of Multidisciplinary Networks in Women’s Hematologic Care
-
Oct 14, 2026, 16:35Thaís Leonel: Analytical Consistency as a Foundation for Evidence-Based Thrombosis Management
-
Oct 14, 2026, 16:28Christina Yiangou: Presenting the HemaFAIR Project at ASCAT 2026 in London
-
Oct 14, 2026, 16:27ITP Research and the Importance of Patient Involvement – ITP Australia and New Zealand
-
Oct 14, 2026, 16:19Ganesh Mohan: Complexities of Thrombosis Care Across Diverse Patient Populations
-
Oct 14, 2026, 16:17Louise St. Germain Bannon: Every Conversation Matters Beyond World Thrombosis Day
-
Oct 14, 2026, 16:11Christina Pierre: A Life-Course Approach to Thrombosis Risk in Women
-
Oct 14, 2026, 16:06Belinda Minnaar: Recognizing Leadership in VTE Prevention on World Thrombosis Day
-
Oct 14, 2026, 14:17Abdul Muqtadir Abbasi: PNH Treatment – Simplified for Medical Students